tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
NASDAQ:TBPH

Compare Theravance Biopharma (TBPH) vs. Competitors

Compare
349 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Theravance Biopharma
$20.33
$1.04B
36.64
141.62%
4 Buy
1 Hold
0 Sell
Strong Buy
Anavex Life Sciences
$4.82
$430.66M
-8.86
-53.96%
1 Buy
1 Hold
0 Sell
Moderate Buy
Maravai Lifesciences Holdings
$3.94
$1.01B
-4.67
-13.22%
3 Buy
1 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$34.45
$3.95B
-36.03
713.57%
10 Buy
0 Hold
0 Sell
Strong Buy
Nanobiotix
$20.07
$1.03B
650.17%
0 Buy
1 Hold
0 Sell
Hold
Day One Biopharmaceuticals
$10.73
$1.20B
-3.85%
8 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TBPH
Theravance Biopharma
20.61
12.17
144.19%
AVXL
Anavex Life Sciences
4.82
-5.33
-52.51%
MRVI
Maravai Lifesciences Holdings
3.94
-0.63
-13.79%
TERN
Terns Pharmaceuticals
37.18
32.68
726.22%
NBTX
Nanobiotix
21.53
18.57
627.36%
DAWN
Day One Biopharmaceuticals
10.73
-1.67
-13.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts